Trade policy was always the right arena for this fight. The U.S.-U.K. deal proves it.
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports.
It’s a perfect example of how the United States can wield trade policy to ensure that other countries pick up a greater share of the global drug-development tab—one commensurate with the value they derive from new medicines.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Trade Policy Is The Right Way To Fight Foreign Freeloading
Sally C. Pipes
Trade policy was always the right arena for this fight. The U.S.-U.K. deal proves it.
Last week, the United States and the United Kingdom announced a trade deal that will require Britain’s National Health Service to pay more for novel prescription drugs in exchange for a reprieve of at least three years from tariffs on its pharmaceutical exports.
It’s a perfect example of how the United States can wield trade policy to ensure that other countries pick up a greater share of the global drug-development tab—one commensurate with the value they derive from new medicines.
Read the op-ed.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.